Chapter V:@0.103809:0.063855:0.209433:0.063855:0.209433:0.040840:0.103809:0.040840:0.016980:0.013076:0.011759:0.013076:0.007832:0.010442:0.010021:0.005456:0.016980
Nilotinib Alleviates Paraquat-Induced Hepatic And  Pulmonary :@0.104762:0.111208:0.902366:0.111208:0.902366:0.083261:0.104762:0.083261:0.020619:0.007939:0.007939:0.014279:0.009510:0.007939:0.015878:0.007939:0.015878:0.010221:0.020619:0.007939:0.007939:0.012680:0.014279:0.007939:0.014279:0.009510:0.012660:0.011109:0.011795:0.017449:0.014279:0.012680:0.014279:0.015878:0.015878:0.014279:0.009510:0.009510:0.011109:0.015878:0.015878:0.015895:0.012680:0.012680:0.015878:0.011795:0.022218:0.012680:0.015878:0.014279:0.009510:0.007939:0.012680:0.010212:0.020619:0.015878:0.015878:0.007140:0.004675:0.017449:0.015878:0.007939:0.023789:0.014279:0.015878:0.014279:0.012680:0.014279:0.007140
Injury In Rats Via The Nrf2/Nf-Kb Axis:@0.104762:0.137337:0.611281:0.137337:0.611281:0.109391:0.104762:0.109391:0.011109:0.015878:0.009510:0.015878:0.012680:0.014279:0.009624:0.011109:0.015878:0.009624:0.020619:0.014279:0.009510:0.011109:0.009121:0.019565:0.007939:0.014279:0.009107:0.019048:0.015878:0.012680:0.009624:0.020619:0.012680:0.011223:0.015993:0.007939:0.020619:0.009510:0.009510:0.022218:0.015878:0.008053:0.020619:0.014279:0.007939:0.011109
International Immunopharmacology. 2023 Nov; 124(Pt A): 110886.:@0.172245:0.161953:0.827755:0.161953:0.827755:0.139687:0.172245:0.139687:0.009149:0.013076:0.006538:0.010442:0.009149:0.013076:0.011759:0.006538:0.006538:0.011759:0.013076:0.011759:0.006538:0.005880:0.009149:0.018297:0.018297:0.013076:0.013076:0.011759:0.011759:0.013076:0.011759:0.009149:0.018297:0.011759:0.010442:0.011759:0.006538:0.011759:0.011759:0.009565:0.005880:0.005880:0.011759:0.011759:0.011759:0.011759:0.005880:0.016980:0.011759:0.010442:0.007832:0.005880:0.011759:0.011759:0.011759:0.007832:0.014370:0.006538:0.004998:0.015687:0.007832:0.007832:0.005880:0.010463:0.011759:0.011759:0.011759:0.011759:0.011759:0.005880
------------------------------------------------------------------------------------:@0.171069:0.188078:0.828929:0.188078:0.828929:0.165678:0.171069:0.165678:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832:0.007832
Azza R Elkholy   , Ahmed R El-Sheakh :@0.190566:0.214202:0.574892:0.214217:0.574892:0.191950:0.190566:0.191936:0.015687:0.009149:0.009149:0.011759:0.005880:0.015687:0.005880:0.015687:0.006538:0.011759:0.013076:0.011759:0.006538:0.010442:0.005880:0.006856:0.005880:0.005880:0.005007:0.015687:0.013076:0.018297:0.010442:0.011759:0.005880:0.015687:0.005880:0.015687:0.006538:0.007832:0.013076:0.013076:0.010442:0.011759:0.011759:0.013076:0.573801
1:@0.345436:0.206550:0.352292:0.206550:0.352292:0.193569:0.345436:0.193569:0.006856
1, 2, 3:@0.574890:0.206550:0.609169:0.206550:0.609169:0.193569:0.574890:0.193569:0.006856:0.003428:0.003428:0.006856:0.003428:0.003428:0.006856
 , Ghada M Suddek :@0.609169:0.214217:0.802561:0.214217:0.802561:0.191950:0.609169:0.191950:0.005880:0.005880:0.005880:0.016980:0.013076:0.011759:0.011759:0.011759:0.005880:0.020908:0.005880:0.013076:0.013076:0.011759:0.011759:0.010442:0.011759:0.005880
1:@0.802576:0.206550:0.809432:0.206550:0.809432:0.193569:0.802576:0.193569:0.006856
Abstract:@0.104762:0.351949:0.213026:0.351949:0.213026:0.324002:0.104762:0.324002:0.020905:0.016164:0.011395:0.009795:0.012965:0.014565:0.012965:0.009510
Background::@0.104762:0.373839:0.219542:0.373839:0.219542:0.354112:0.104762:0.354112:0.013647:0.010281:0.009152:0.011410:0.010281:0.008785:0.010281:0.011410:0.011410:0.011410:0.006713
  Paraquat  (PQ,  1,1′-dimethyl-4-4′-bipyridinium  dichloride)  is  a  highly  toxic :@0.219743:0.373540:0.900352:0.373540:0.900352:0.354340:0.219743:0.354340:0.005040:0.006624:0.011410:0.009152:0.006914:0.009152:0.010281:0.010281:0.009152:0.005806:0.005040:0.006624:0.006914:0.011410:0.014756:0.005241:0.005040:0.006624:0.010281:0.005241:0.010281:0.004616:0.006914:0.010281:0.005806:0.015885:0.009152:0.005806:0.010281:0.010281:0.005806:0.006914:0.010281:0.006914:0.010281:0.004616:0.006914:0.010281:0.005806:0.010281:0.010281:0.006914:0.005806:0.010281:0.005806:0.010281:0.005806:0.010281:0.015885:0.005040:0.006624:0.010281:0.005806:0.009152:0.010281:0.005806:0.010281:0.006914:0.005806:0.010281:0.009152:0.006914:0.005040:0.006622:0.005806:0.008043:0.005040:0.006624:0.009152:0.005040:0.006624:0.010281:0.005806:0.010281:0.010281:0.005806:0.010281:0.005040:0.006622:0.005806:0.010281:0.010281:0.005806:0.008948:0.005040
quaternary ammonium herbicide widely used in agriculture. It exerts its toxic effects mainly :@0.104762:0.390644:0.900487:0.390644:0.900487:0.371444:0.104762:0.371444:0.010281:0.010281:0.009152:0.005806:0.009152:0.006914:0.010281:0.009152:0.006914:0.010281:0.007721:0.009152:0.015885:0.015885:0.010281:0.010281:0.005806:0.010281:0.015885:0.007721:0.010281:0.009152:0.006914:0.010281:0.005806:0.009152:0.005806:0.010281:0.009152:0.007721:0.014756:0.005806:0.010281:0.009152:0.005806:0.010281:0.007721:0.010281:0.008043:0.009152:0.010281:0.007721:0.005806:0.010281:0.007721:0.009152:0.010281:0.006914:0.005806:0.009152:0.010281:0.005806:0.005806:0.010281:0.006914:0.009152:0.005241:0.007721:0.006914:0.005806:0.007721:0.009152:0.010281:0.009152:0.006914:0.005806:0.008043:0.007721:0.005806:0.005806:0.008043:0.007721:0.005806:0.010281:0.010281:0.005806:0.009152:0.007721:0.009152:0.006552:0.006914:0.009152:0.009152:0.005806:0.008043:0.007721:0.015885:0.009152:0.005806:0.010281:0.005806:0.010079:0.005040
as a result of its redox cycle via the production of superoxide anions in organisms, leading to :@0.104762:0.407748:0.900434:0.407748:0.900434:0.388549:0.104762:0.388549:0.009152:0.008043:0.006713:0.009152:0.006713:0.006914:0.009152:0.008043:0.010281:0.005806:0.005806:0.006703:0.010281:0.006914:0.006703:0.005806:0.005806:0.008043:0.006703:0.006914:0.009152:0.010281:0.010281:0.010281:0.006713:0.009152:0.010281:0.009152:0.005806:0.009152:0.006703:0.010281:0.005806:0.009152:0.006713:0.005806:0.010281:0.009152:0.006703:0.010281:0.006914:0.010281:0.010281:0.010281:0.009152:0.005806:0.005806:0.010281:0.010281:0.006713:0.010281:0.006914:0.006703:0.008043:0.010281:0.010281:0.009152:0.006914:0.010281:0.010281:0.005806:0.010281:0.009152:0.006703:0.009152:0.010281:0.005806:0.010281:0.010281:0.008043:0.006713:0.005806:0.010281:0.006713:0.010281:0.006550:0.010281:0.009152:0.010281:0.005806:0.008043:0.015885:0.008043:0.005241:0.006713:0.005806:0.009152:0.009152:0.010281:0.005806:0.010281:0.010281:0.006713:0.005806:0.010079:0.005040
an imbalance in the redox state of the cell causing oxidative damage and finally cell death. The :@0.104762:0.424853:0.900497:0.424853:0.900497:0.405653:0.104762:0.405653:0.009152:0.010281:0.005584:0.005806:0.015885:0.010281:0.009152:0.005806:0.009152:0.010281:0.009152:0.009152:0.005584:0.005806:0.010281:0.005584:0.005806:0.010281:0.009152:0.005584:0.006914:0.009152:0.010281:0.010281:0.010281:0.005584:0.008043:0.005806:0.009152:0.005806:0.009152:0.005584:0.010281:0.006914:0.005584:0.005806:0.010281:0.009152:0.005584:0.009152:0.009152:0.005806:0.005806:0.005584:0.009152:0.009152:0.010281:0.008043:0.005806:0.010281:0.010281:0.005584:0.010281:0.010281:0.005806:0.010281:0.009152:0.005806:0.005806:0.010281:0.009152:0.005584:0.010281:0.009152:0.015885:0.009152:0.010281:0.009152:0.005584:0.009152:0.010281:0.010281:0.005584:0.006914:0.005806:0.010281:0.009152:0.005806:0.005806:0.010281:0.005584:0.009152:0.009152:0.005806:0.005806:0.005584:0.010281:0.009152:0.009152:0.005806:0.010281:0.005241:0.005213:0.012519:0.010281:0.008948:0.005040
aim of this study was to estimate the beneficial protective role of nilotinib (NIL) on PQ-induced :@0.104762:0.441957:0.900469:0.441957:0.900469:0.422757:0.104762:0.422757:0.009152:0.005806:0.015885:0.005040:0.010281:0.006914:0.005040:0.005806:0.010281:0.005806:0.008043:0.005040:0.008043:0.005806:0.010281:0.010281:0.010281:0.005040:0.014756:0.009152:0.008043:0.005040:0.005806:0.010281:0.005040:0.009152:0.008043:0.005806:0.005806:0.015885:0.009152:0.005806:0.009152:0.005040:0.005806:0.010281:0.009152:0.005040:0.010281:0.009152:0.010281:0.009152:0.006914:0.005806:0.009152:0.005806:0.009152:0.005806:0.005040:0.010281:0.006914:0.010281:0.005806:0.009152:0.009152:0.005806:0.005806:0.010281:0.009152:0.005040:0.006914:0.010281:0.005806:0.009152:0.005040:0.010281:0.006914:0.005040:0.010281:0.005806:0.005806:0.010281:0.005806:0.005806:0.010281:0.005806:0.010281:0.005040:0.006914:0.014756:0.006914:0.012519:0.006914:0.005040:0.010281:0.010281:0.005040:0.011410:0.014756:0.006914:0.005806:0.010281:0.010281:0.010281:0.009152:0.009152:0.010081:0.005040
hepatic and pulmonary toxicity in rats.:@0.104762:0.459062:0.432805:0.459062:0.432805:0.439862:0.104762:0.439862:0.010281:0.009152:0.010281:0.009152:0.005806:0.005806:0.009152:0.007056:0.009152:0.010281:0.010281:0.007056:0.010281:0.010281:0.005806:0.015885:0.010281:0.010281:0.009152:0.006914:0.010281:0.007056:0.005806:0.010281:0.010281:0.005806:0.009152:0.005806:0.005806:0.010281:0.007056:0.005806:0.010281:0.007056:0.006914:0.009152:0.005806:0.008043:0.005040
Methods::@0.104762:0.483193:0.187917:0.483193:0.187917:0.463466:0.104762:0.463466:0.019231:0.009152:0.006914:0.011410:0.010281:0.011410:0.008043:0.006713
 Male wistar rats were randomly divided into four groups, namely control, PQ (15 mg/:@0.188118:0.482894:0.895316:0.482894:0.895316:0.463694:0.188118:0.463694:0.004737:0.018123:0.009152:0.005806:0.009152:0.004727:0.014756:0.005806:0.008043:0.005806:0.009152:0.006914:0.004727:0.006914:0.009152:0.005806:0.008043:0.004727:0.014756:0.009152:0.006914:0.009152:0.004727:0.006914:0.009152:0.010281:0.010281:0.010281:0.015885:0.005806:0.010281:0.004727:0.010281:0.005806:0.010281:0.005806:0.010281:0.009152:0.010281:0.004727:0.005806:0.010281:0.005806:0.010281:0.004727:0.006914:0.010281:0.010281:0.006914:0.004737:0.010281:0.006914:0.010281:0.010281:0.010281:0.008043:0.005241:0.004727:0.010281:0.009152:0.015885:0.009152:0.005806:0.010281:0.004727:0.009152:0.010281:0.010281:0.005806:0.006914:0.010281:0.005806:0.005241:0.004727:0.011410:0.014756:0.004737:0.006914:0.010281:0.010281:0.004727:0.015885:0.010281:0.005604
kg), PQ plus NIL (5 mg/kg) and PQ plus NIL (10 mg/kg). NIL (5 and 10 mg/kg/day) was taken :@0.104762:0.499998:0.900432:0.499998:0.900432:0.480798:0.104762:0.480798:0.010281:0.010281:0.006914:0.005241:0.005503:0.011410:0.014756:0.005503:0.010281:0.005806:0.010281:0.008043:0.005503:0.014756:0.006914:0.011769:0.005503:0.006914:0.010281:0.005503:0.015885:0.010281:0.005806:0.010281:0.010281:0.006914:0.005503:0.009152:0.010281:0.010281:0.005503:0.011410:0.014756:0.005503:0.010281:0.005806:0.010281:0.008043:0.005503:0.014756:0.006914:0.011769:0.005503:0.006914:0.010281:0.010281:0.005503:0.015885:0.010281:0.005806:0.010281:0.010281:0.006914:0.005241:0.005503:0.014756:0.006914:0.011767:0.005503:0.006914:0.010281:0.005503:0.009152:0.010281:0.010281:0.005503:0.010281:0.010281:0.005503:0.015885:0.010281:0.005806:0.010281:0.010281:0.005806:0.010281:0.009152:0.010281:0.006914:0.005503:0.014756:0.009152:0.008043:0.005503:0.005806:0.009152:0.010281:0.009152:0.010079:0.005040
by oral syringe for five days followed by a single intra-peritoneal administration of PQ (15 mg/:@0.104762:0.517102:0.895367:0.517102:0.895367:0.497903:0.104762:0.497903:0.010281:0.010281:0.005423:0.010281:0.006914:0.009152:0.005806:0.005423:0.008043:0.010281:0.006914:0.005806:0.010281:0.010281:0.009152:0.005423:0.006914:0.010281:0.006914:0.005423:0.006914:0.005806:0.010281:0.009152:0.005423:0.010281:0.009152:0.010281:0.008043:0.005423:0.006914:0.010281:0.005806:0.005806:0.010281:0.014756:0.009152:0.010281:0.005423:0.010281:0.010281:0.005423:0.009152:0.005423:0.008043:0.005806:0.010281:0.010281:0.005806:0.009152:0.005423:0.005806:0.010281:0.005806:0.006914:0.009152:0.006914:0.010281:0.009152:0.006914:0.005806:0.005806:0.010281:0.010281:0.009152:0.009152:0.005806:0.005423:0.009152:0.010281:0.015885:0.005806:0.010281:0.005806:0.008043:0.005806:0.006914:0.009152:0.005806:0.005806:0.010281:0.010281:0.005423:0.010281:0.006914:0.005423:0.011410:0.014756:0.005423:0.006914:0.010281:0.010281:0.005423:0.015885:0.010281:0.005604
kg) on sixth day.:@0.104762:0.534207:0.242186:0.534207:0.242186:0.515007:0.104762:0.515007:0.010281:0.010281:0.006914:0.005241:0.010281:0.010281:0.005241:0.008043:0.005806:0.010281:0.005806:0.010281:0.005241:0.010281:0.009152:0.008973:0.005040
Results::@0.104762:0.558338:0.175600:0.558338:0.175600:0.538611:0.104762:0.538611:0.014756:0.009152:0.008043:0.011410:0.005806:0.006914:0.008043:0.006713
 Pretreatment with NIL relieved the histological damage in liver and lung tissues :@0.175801:0.558039:0.900283:0.558039:0.900283:0.538839:0.175801:0.538839:0.009696:0.011410:0.006914:0.009152:0.005806:0.006914:0.009152:0.009152:0.005806:0.015885:0.009152:0.010281:0.005806:0.009696:0.014756:0.005806:0.005806:0.010281:0.009696:0.014756:0.006914:0.011767:0.009696:0.006914:0.009152:0.005806:0.005806:0.009152:0.010281:0.009152:0.010281:0.009696:0.005806:0.010281:0.009152:0.009696:0.010281:0.005806:0.008043:0.005806:0.010281:0.005806:0.010281:0.010281:0.005806:0.009152:0.009152:0.005806:0.009696:0.010281:0.009152:0.015885:0.009152:0.010281:0.009152:0.009696:0.005806:0.010281:0.009696:0.005806:0.005806:0.010281:0.009152:0.006914:0.009696:0.009152:0.010281:0.010281:0.009696:0.005806:0.010281:0.010281:0.010281:0.009696:0.005806:0.005806:0.008043:0.008043:0.010281:0.009152:0.007846:0.005040
and improved hepatic biochemical markers. It  significantly (p < 0.05) reduced  serum levels :@0.104762:0.575143:0.900469:0.575143:0.900469:0.555944:0.104762:0.555944:0.009152:0.010281:0.010281:0.008225:0.005806:0.015885:0.010281:0.006914:0.010281:0.010281:0.009152:0.010281:0.008225:0.010281:0.009152:0.010281:0.009152:0.005806:0.005806:0.009152:0.008225:0.010281:0.005806:0.010281:0.009152:0.010281:0.009152:0.015885:0.005806:0.009152:0.009152:0.005806:0.008225:0.015885:0.009152:0.006914:0.010281:0.009152:0.006914:0.008043:0.005241:0.008225:0.006914:0.005806:0.005040:0.003175:0.008043:0.005806:0.010281:0.010281:0.005806:0.006914:0.005806:0.009152:0.009152:0.010281:0.005806:0.005806:0.010281:0.008225:0.006914:0.010281:0.008225:0.011571:0.008225:0.010281:0.005241:0.010281:0.010281:0.006914:0.008225:0.006914:0.009152:0.010281:0.010281:0.009152:0.009152:0.010281:0.005040:0.003175:0.008043:0.009152:0.006914:0.010281:0.015885:0.008225:0.005806:0.009152:0.010281:0.009152:0.005806:0.007844:0.005040
of ALT, AST, ALP, Y-GT and total bilirubin while increased that of albumin. Meanwhile, NIL :@0.104762:0.592248:0.900313:0.592248:0.900313:0.573048:0.104762:0.573048:0.010281:0.006914:0.005443:0.014756:0.010664:0.011019:0.005241:0.005443:0.014756:0.011410:0.011021:0.005241:0.005441:0.014756:0.012519:0.009178:0.005241:0.005806:0.012525:0.006914:0.014756:0.012152:0.006552:0.009152:0.010281:0.010281:0.006552:0.005806:0.010281:0.005806:0.009152:0.005806:0.006552:0.010281:0.005806:0.005806:0.005806:0.006914:0.010281:0.010281:0.005806:0.010281:0.006552:0.014756:0.010281:0.005806:0.005806:0.009152:0.006552:0.005806:0.010281:0.009152:0.006914:0.009152:0.009152:0.008043:0.009152:0.010281:0.006552:0.005806:0.010281:0.009152:0.005806:0.006552:0.010281:0.006914:0.006552:0.009152:0.005806:0.010281:0.010281:0.015885:0.005806:0.010281:0.005241:0.006552:0.018123:0.009152:0.009152:0.010281:0.014756:0.010281:0.005806:0.005806:0.009152:0.005241:0.006552:0.014756:0.006914:0.011567:0.005040
significantly (p < 0.05) reduced oxidative stress markers via reduction of malondialdhyde (MDA) :@0.104762:0.609352:0.900447:0.609352:0.900447:0.590152:0.104762:0.590152:0.008043:0.005806:0.010281:0.010281:0.005806:0.006914:0.005806:0.009152:0.009152:0.010281:0.005806:0.005806:0.010281:0.003891:0.006914:0.010281:0.003891:0.011571:0.003891:0.010281:0.005241:0.010281:0.010281:0.006914:0.003891:0.006914:0.009152:0.010281:0.010281:0.009152:0.009152:0.010281:0.003891:0.010281:0.010281:0.005806:0.010281:0.009152:0.005806:0.005806:0.010281:0.009152:0.003891:0.008043:0.005806:0.006914:0.009152:0.008043:0.008043:0.003891:0.015885:0.009152:0.006914:0.010281:0.009152:0.006914:0.008043:0.003891:0.010281:0.005806:0.009152:0.003891:0.006914:0.009152:0.010281:0.010281:0.009152:0.005806:0.005806:0.010281:0.010281:0.003891:0.010281:0.006914:0.003891:0.015885:0.009152:0.005806:0.010281:0.010281:0.010281:0.005806:0.009152:0.005806:0.010281:0.010281:0.010281:0.010281:0.009152:0.003891:0.006914:0.018123:0.014756:0.014756:0.006713:0.005040
and elevation of glutathione (GSH) contents in liver and lung tissues. In addition, it significantly :@0.104762:0.626456:0.900449:0.626456:0.900449:0.607257:0.104762:0.607257:0.009152:0.010281:0.010281:0.004697:0.009152:0.005806:0.009152:0.010281:0.009152:0.005806:0.005806:0.010281:0.010281:0.004697:0.010281:0.006914:0.004697:0.010281:0.005806:0.010281:0.005806:0.009152:0.005806:0.010281:0.005806:0.010281:0.010281:0.009152:0.004697:0.006914:0.014756:0.011410:0.014756:0.006914:0.004697:0.009152:0.010281:0.010281:0.005806:0.009152:0.010281:0.005806:0.008043:0.004697:0.005806:0.010281:0.004697:0.005806:0.005806:0.010281:0.009152:0.006914:0.004697:0.009152:0.010281:0.010281:0.004697:0.005806:0.010281:0.010281:0.010281:0.004697:0.005806:0.005806:0.008043:0.008043:0.010281:0.009152:0.008043:0.005241:0.004697:0.006914:0.010281:0.004697:0.009152:0.010281:0.010281:0.005806:0.005806:0.005806:0.010281:0.010281:0.005241:0.004697:0.005806:0.005806:0.004697:0.008043:0.005806:0.010281:0.010281:0.005806:0.006914:0.005806:0.009152:0.009152:0.010281:0.005806:0.005806:0.010081:0.005040
(p < 0.05) decreased the inflammation by reducing hepatic and pulmonary tumor necrosis factor :@0.104762:0.643561:0.900467:0.643561:0.900467:0.624361:0.104762:0.624361:0.006914:0.010281:0.005020:0.011571:0.005020:0.010281:0.005241:0.010281:0.010281:0.006914:0.005020:0.010281:0.009152:0.009152:0.006914:0.009152:0.009152:0.008043:0.009152:0.010281:0.005020:0.005806:0.010281:0.009152:0.005020:0.005806:0.010281:0.006914:0.005806:0.009152:0.015885:0.015885:0.009152:0.005806:0.005806:0.010281:0.010281:0.005020:0.010281:0.010281:0.005020:0.006914:0.009152:0.010281:0.010281:0.009152:0.005806:0.010281:0.010281:0.005020:0.010281:0.009152:0.010281:0.009152:0.005806:0.005806:0.009152:0.005020:0.009152:0.010281:0.010281:0.005020:0.010281:0.010281:0.005806:0.015885:0.010281:0.010281:0.009152:0.006914:0.010281:0.005020:0.005806:0.010281:0.015885:0.010281:0.006914:0.005020:0.010281:0.009152:0.009152:0.006914:0.010281:0.008043:0.005806:0.008043:0.005020:0.006914:0.009152:0.009152:0.005806:0.010281:0.006713:0.005040
alpha (TNF-α) and nuclear transcription factor kappa B (NF-KB/p65) contents. Nilotinib also :@0.104762:0.660665:0.900350:0.660665:0.900350:0.641465:0.104762:0.641465:0.009152:0.005806:0.010281:0.010281:0.009152:0.006906:0.006914:0.012519:0.014756:0.011410:0.006914:0.010765:0.006914:0.006906:0.009152:0.010281:0.010281:0.006908:0.010281:0.010281:0.009152:0.005806:0.009152:0.009152:0.006914:0.006908:0.005806:0.006914:0.009152:0.010281:0.008043:0.009152:0.006914:0.005806:0.010281:0.005806:0.005806:0.010281:0.010281:0.006908:0.006914:0.009152:0.009152:0.005806:0.010281:0.006914:0.006906:0.010281:0.009152:0.010281:0.010281:0.009152:0.006906:0.013647:0.006908:0.006914:0.014756:0.011410:0.006914:0.014756:0.013647:0.005806:0.010281:0.010281:0.010281:0.006914:0.006908:0.009152:0.010281:0.010281:0.005806:0.009152:0.010281:0.005806:0.008043:0.005241:0.006908:0.014756:0.005806:0.005806:0.010281:0.005806:0.005806:0.010281:0.005806:0.010281:0.006906:0.009152:0.005806:0.008043:0.010079:0.005040
down-regulated apoptosis by reducing cysteinyl aspartate-specific proteinase-3 (caspase-3). :@0.104762:0.677769:0.900346:0.677769:0.900346:0.658570:0.104762:0.658570:0.010281:0.010281:0.014756:0.010281:0.006914:0.006914:0.009152:0.010281:0.010281:0.005806:0.009152:0.005806:0.009152:0.010281:0.010019:0.009152:0.010281:0.010281:0.010281:0.005806:0.010281:0.008043:0.005806:0.008043:0.010019:0.010281:0.010281:0.010019:0.006914:0.009152:0.010281:0.010281:0.009152:0.005806:0.010281:0.010281:0.010019:0.009152:0.010281:0.008043:0.005806:0.009152:0.005806:0.010281:0.010281:0.005806:0.010019:0.009152:0.008043:0.010281:0.009152:0.006914:0.005806:0.009152:0.005806:0.009152:0.006914:0.008043:0.010281:0.009152:0.009152:0.005806:0.006914:0.005806:0.009152:0.010019:0.010281:0.006914:0.010281:0.005806:0.009152:0.005806:0.010281:0.009152:0.008043:0.009152:0.006914:0.010281:0.010019:0.006914:0.009152:0.009152:0.008043:0.010281:0.009152:0.008043:0.009152:0.006914:0.010281:0.006914:0.005040:0.005040
Furthermore, it upregulated the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) :@0.104762:0.694874:0.900368:0.694874:0.900368:0.675674:0.104762:0.675674:0.011410:0.010281:0.006914:0.005806:0.010281:0.009152:0.006914:0.015885:0.010281:0.006914:0.009152:0.005241:0.006128:0.005806:0.005806:0.006128:0.010281:0.010281:0.006914:0.009152:0.010281:0.010281:0.005806:0.009152:0.005806:0.009152:0.010281:0.006128:0.005806:0.010281:0.009152:0.006128:0.009152:0.010281:0.010281:0.006914:0.009152:0.008043:0.008043:0.005806:0.010281:0.010281:0.006128:0.010281:0.006914:0.006128:0.010281:0.010281:0.009152:0.005806:0.009152:0.009152:0.006914:0.006128:0.006914:0.009152:0.009152:0.005806:0.010281:0.006914:0.006128:0.009152:0.006914:0.010281:0.005806:0.010281:0.006914:0.010281:0.005806:0.010281:0.006128:0.010281:0.006914:0.006914:0.009152:0.005806:0.009152:0.005806:0.009152:0.010281:0.006128:0.006914:0.009152:0.009152:0.005806:0.010281:0.006914:0.006128:0.010281:0.006128:0.006914:0.014756:0.006914:0.006914:0.010281:0.006715:0.005040
and microtubule-associated protein 1A/1B-light chain 3 II (LC3II) in liver and lung tissues.:@0.104762:0.711978:0.876649:0.711978:0.876649:0.692779:0.104762:0.692779:0.009152:0.010281:0.010281:0.006582:0.015885:0.005806:0.009152:0.006914:0.010281:0.005806:0.010281:0.010281:0.010281:0.005806:0.009152:0.006914:0.009152:0.008043:0.008043:0.010281:0.009152:0.005806:0.009152:0.005806:0.009152:0.010281:0.006582:0.010281:0.006914:0.010281:0.005806:0.009152:0.005806:0.010281:0.006592:0.010281:0.014756:0.005806:0.010281:0.013647:0.006914:0.005806:0.005806:0.010281:0.010281:0.005806:0.006592:0.009152:0.010281:0.009152:0.005806:0.010281:0.006592:0.010281:0.006592:0.006914:0.006914:0.006592:0.006914:0.012519:0.013647:0.010281:0.006914:0.006914:0.006914:0.006582:0.005806:0.010281:0.006592:0.005806:0.005806:0.010281:0.009152:0.006914:0.006592:0.009152:0.010281:0.010281:0.006582:0.005806:0.010281:0.010281:0.010281:0.006582:0.005806:0.005806:0.008043:0.008043:0.010281:0.009152:0.008043:0.005040
Significance::@0.104762:0.736110:0.218054:0.736110:0.218054:0.716383:0.104762:0.716383:0.011410:0.005806:0.010281:0.011410:0.005806:0.006914:0.005806:0.009152:0.010281:0.011410:0.009152:0.009152:0.006713
 NIL suppressed PQ-induced inflammation, oxidative stress and apoptosis in liver :@0.218255:0.735810:0.900420:0.735810:0.900420:0.716611:0.218255:0.716611:0.005423:0.014756:0.006914:0.011767:0.005423:0.008043:0.010281:0.010281:0.010281:0.006914:0.009152:0.008043:0.008043:0.009152:0.010281:0.005423:0.011410:0.014756:0.006914:0.005806:0.010281:0.010281:0.010281:0.009152:0.009152:0.010281:0.005423:0.005806:0.010281:0.006914:0.005806:0.009152:0.015885:0.015885:0.009152:0.005806:0.005806:0.010281:0.010281:0.005241:0.005423:0.010281:0.010281:0.005806:0.010281:0.009152:0.005806:0.005806:0.010281:0.009152:0.005423:0.008043:0.005806:0.006914:0.009152:0.008043:0.008043:0.005423:0.009152:0.010281:0.010281:0.005423:0.009152:0.010281:0.010281:0.010281:0.005806:0.010281:0.008043:0.005806:0.008043:0.005423:0.005806:0.010281:0.005423:0.005806:0.005806:0.010281:0.009152:0.006713:0.005040
and lung tissues by modulating Nrf2/Nf-kB axis.:@0.104762:0.752915:0.508521:0.752915:0.508521:0.733715:0.104762:0.733715:0.009152:0.010281:0.010281:0.005382:0.005806:0.010281:0.010281:0.010281:0.005382:0.005806:0.005806:0.008043:0.008043:0.010281:0.009152:0.008043:0.005382:0.010281:0.010281:0.005382:0.015885:0.010281:0.010281:0.010281:0.005806:0.009152:0.005806:0.005806:0.010281:0.010281:0.005382:0.014756:0.006914:0.006914:0.010281:0.005806:0.014756:0.006914:0.006914:0.010281:0.013647:0.005382:0.009152:0.010281:0.005806:0.008043:0.005040
1:@0.104762:0.232332:0.109659:0.232332:0.109659:0.223005:0.104762:0.223005:0.004897
 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.:@0.109757:0.237808:0.862421:0.237808:0.862421:0.221809:0.109757:0.221809:0.004368:0.012297:0.007627:0.008567:0.007627:0.005762:0.004838:0.013238:0.007627:0.008567:0.004838:0.004368:0.008567:0.005762:0.004368:0.009508:0.008567:0.007627:0.005762:0.013238:0.007627:0.007627:0.008567:0.004838:0.008567:0.008567:0.008567:0.004368:0.007627:0.008567:0.008567:0.004064:0.009258:0.008567:0.008567:0.004838:0.007627:0.008567:0.004838:0.008567:0.008567:0.007477:0.004368:0.004368:0.009508:0.007627:0.007627:0.008567:0.004838:0.004838:0.008567:0.004368:0.008567:0.005762:0.004368:0.009508:0.008567:0.007627:0.005762:0.013238:0.007627:0.007627:0.007477:0.004368:0.004368:0.015102:0.007627:0.008567:0.006703:0.008567:0.008567:0.005762:0.007627:0.004368:0.012297:0.008567:0.004838:0.008567:0.007627:0.005762:0.006703:0.004838:0.004838:0.007477:0.004368:0.004368:0.015102:0.007627:0.008567:0.006703:0.008567:0.008567:0.005762:0.007627:0.004368:0.004368:0.010432:0.008567:0.008567:0.008567:0.004838:0.004200
2:@0.104762:0.253320:0.109659:0.253320:0.109659:0.243992:0.104762:0.243992:0.004897
 Department of Pharmacology and Toxicology, Faculty of Pharmacy,:@0.109757:0.258796:0.602599:0.258796:0.602599:0.242796:0.109757:0.242796:0.006904:0.012297:0.007627:0.008567:0.007627:0.005762:0.004838:0.013238:0.007627:0.008567:0.004838:0.006904:0.008567:0.005762:0.006904:0.009508:0.008567:0.007627:0.005762:0.013238:0.007627:0.007627:0.008567:0.004838:0.008567:0.008567:0.008567:0.006904:0.007627:0.008567:0.008567:0.006595:0.009256:0.008567:0.008567:0.004838:0.007627:0.008567:0.004838:0.008567:0.008567:0.007477:0.004368:0.006904:0.009508:0.007627:0.007627:0.008567:0.004838:0.004838:0.008567:0.006904:0.008567:0.005762:0.006904:0.009508:0.008567:0.007627:0.005762:0.013238:0.007627:0.007627:0.007476:0.004200
 :@0.602767:0.258796:0.606966:0.258796:0.606966:0.242796:0.602767:0.242796:0.004200
Mansoura National University,:@0.609575:0.258796:0.828879:0.258796:0.828879:0.242998:0.609575:0.242998:0.014161:0.008567:0.008567:0.006703:0.008567:0.008567:0.006703:0.008567:0.006904:0.011373:0.008567:0.004838:0.004838:0.008567:0.008567:0.008567:0.004838:0.006904:0.012297:0.008567:0.004838:0.007627:0.007627:0.006703:0.006703:0.004838:0.004838:0.006696:0.004200
  Gamasa,    :@0.829047:0.258796:0.899463:0.258796:0.899463:0.242796:0.829047:0.242796:0.004200:0.002700:0.012297:0.007627:0.013238:0.007627:0.006703:0.007627:0.004200:0.000000:0.000000:0.000000:0.004200
Egypt.:@0.119046:0.273050:0.166018:0.273050:0.166018:0.257050:0.119046:0.257050:0.010790:0.008929:0.008929:0.008929:0.005196:0.004200
3:@0.104762:0.288561:0.109659:0.288561:0.109659:0.279234:0.104762:0.279234:0.004897
 Future studies and Risks management’ National Committee of Drugs, Academy of Scientific Research, Ministry of :@0.109757:0.294037:0.899503:0.294037:0.899503:0.278038:0.109757:0.278038:0.003746:0.009508:0.008567:0.004838:0.008567:0.005762:0.007627:0.003746:0.006703:0.004838:0.008567:0.008567:0.004838:0.007627:0.006703:0.003746:0.007627:0.008567:0.008567:0.003746:0.011373:0.004838:0.006703:0.008567:0.006703:0.003746:0.013238:0.007627:0.008567:0.007627:0.008567:0.007627:0.013238:0.007627:0.008567:0.004838:0.004516:0.003746:0.012297:0.007627:0.004838:0.004838:0.008567:0.008567:0.007627:0.004838:0.003746:0.011373:0.008567:0.013238:0.013238:0.004838:0.004838:0.004838:0.007627:0.007627:0.003746:0.008567:0.005762:0.003746:0.012297:0.005762:0.008567:0.008567:0.006703:0.004368:0.002821:0.012297:0.007627:0.007627:0.008567:0.007627:0.013238:0.008567:0.003746:0.008567:0.005762:0.003746:0.009508:0.007627:0.004838:0.007627:0.008567:0.004838:0.004838:0.005762:0.004838:0.007627:0.003746:0.011373:0.007627:0.006703:0.007627:0.007627:0.005762:0.007627:0.008567:0.004368:0.003746:0.015102:0.004838:0.008567:0.004838:0.006703:0.004838:0.005762:0.008567:0.003746:0.008567:0.005594:0.004200
Higher Education, Elsayeda Zeinab, Egypt.:@0.119046:0.308291:0.413868:0.308291:0.413868:0.292291:0.119046:0.292291:0.012297:0.004838:0.008567:0.008567:0.007627:0.005762:0.003494:0.010432:0.008567:0.008567:0.007627:0.007627:0.004838:0.004838:0.008567:0.008567:0.004368:0.003494:0.010432:0.004838:0.006703:0.007627:0.008567:0.007627:0.008567:0.007627:0.003494:0.010432:0.007627:0.004838:0.008567:0.007627:0.008567:0.004368:0.003494:0.010432:0.008567:0.008567:0.008567:0.004838:0.004200
Faculty of Pharmacy Newsletter:@0.147970:0.965677:0.401979:0.965677:0.401979:0.947594:0.147970:0.947594:0.011291:0.009239:0.008205:0.010274:0.005137:0.006153:0.009239:0.004620:0.009239:0.006153:0.004620:0.011291:0.010274:0.009239:0.008205:0.015393:0.009239:0.008205:0.009239:0.004620:0.013342:0.008205:0.013342:0.007188:0.005137:0.008205:0.006153:0.006153:0.008205:0.008205
94:@0.104524:0.971012:0.136879:0.971012:0.136879:0.940075:0.104524:0.940075:0.015815:0.016540
Reference::@0.104524:0.808587:0.210310:0.808587:0.210310:0.786320:0.104524:0.786320:0.015687:0.010442:0.007832:0.010442:0.009149:0.010442:0.013076:0.010442:0.010442:0.007832
https://doi.org/10.1016/j.intimp.2023.110886:@0.104524:0.828116:0.407388:0.828116:0.407388:0.812116:0.104524:0.812116:0.008399:0.004670:0.004670:0.008399:0.006535:0.004670:0.004670:0.004670:0.008399:0.008399:0.004670:0.004200:0.008399:0.005277:0.008399:0.004670:0.008399:0.008399:0.004200:0.008399:0.008399:0.008399:0.008399:0.004670:0.004670:0.004200:0.004670:0.008399:0.004670:0.004670:0.013070:0.008399:0.004200:0.008399:0.008399:0.008399:0.008399:0.004200:0.007756:0.008399:0.008399:0.008399:0.008399:0.008399